Aktiia, Optical Health Monitoring Firm, Gains $30M in Funding
NEUCHÂTEL, Switzerland, Feb. 29, 2024 — Aktiia, a developer of optical health monitoring technology, has completed a CHF 27 million ($30 million) funding round. The company's wrist-worn, 24/7 optical blood pressure monitoring device, which is currently marketed in seven European markets and approved as a medical device in 44 countries, uses photoplethysmography to determine blood volume changes in small blood vessels. The wristbands are calibrated monthly using a conventional blood pressure monitor.